Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
Z339716-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $294.90 |
a novel metabolite of tamoxifen
Synonyms | Endoxifen|112093-28-4|Z-Endoxifen|4-Hydroxy-N-desmethyltamoxifen|Endoxifen Z-Isomer|N-Desmethyl-4-hydroxytamoxifen|(Z)-Endoxifen|110025-28-0|4OHNDtam|NSC-749798|4-Hydroxy-N-desmethyl-tamoxifen|CHEBI:80555|46AF8680RC|4-[(Z)-1-[4-[2-(methylamino)ethoxy]phen |
---|---|
Specifications & Purity | Moligand™ |
Storage Temp | Store at -80°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of CYP19A1 |
Product Description | (Z)-4-Hydroxy-N-desmethyl Tamoxifen (mixture of isomers) is a novel active metabolite of the anti-cancer drug, Tamoxifen , and it contains up to 10% E isomer. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 4-[(Z)-1-[4-[2-(methylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol |
---|---|
INCHI | InChI=1S/C25H27NO2/c1-3-24(19-7-5-4-6-8-19)25(20-9-13-22(27)14-10-20)21-11-15-23(16-12-21)28-18-17-26-2/h4-16,26-27H,3,17-18H2,1-2H3/b25-24- |
InChi Key | MHJBZVSGOZTKRH-IZHYLOQSSA-N |
Canonical SMILES | CCC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)OCCNC)C3=CC=CC=C3 |
Isomeric SMILES | CC/C(=C(\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)OCCNC)/C3=CC=CC=C3 |
Alternate CAS | 112093-28-4,110025-28-0 |
PubChem CID | 10090750 |
NSC Number | 746494 |
MeSH Entry Terms | 4-hydroxy-N-demethyltamoxifen;4-hydroxy-N-desmethyltamoxifen;4-hydroxy-N-desmethyltamoxifen, (Z)-isomer;endoxifen;Z-endoxifen |
Molecular Weight | 373.49 |
Enter Lot Number to search for COA:
Solubility | Soluble in Chloroform |
---|---|
Melt Point(°C) | 127-129 |
Pictogram(s) | GHS08, GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H413:May cause long lasting harmful effects to aquatic life H302:Harmful if swallowed H312:Harmful in contact with skin H332:Harmful if inhaled H302+H312+H332:Harmful if swallowed, in contact with skin or if inhaled H361:Suspected of damaging fertility or the unborn child |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P273:Avoid release to the environment. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P271:Use only outdoors or in a well-ventilated area. P270:Do not eat, drink or smoke when using this product. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P362+P364:Take off contaminated clothing and wash it before reuse. P330:Rinse mouth. P203:Obtain, read and follow all safety instructions before use. P301+P317:IF SWALLOWED: Get medical help. P318:if exposed or concerned, get medical advice. P317:Get emergency medical help. |
1. Maksina AG, Daĭniak BA, Rakhmanova IV. (1988) [Use of the spin label method for studying the structure of the brain membranes in cats with streptomycin poisoning].. Nauchnye Doki Vyss Shkoly Biol Nauki, 129 (11): (61-4). [PMID:2852035] |
2. Ma J, Chu Z, Lu JBL, Liu J, Zhang Q, Liu Z, Tang D. (2018) The Cytochrome P450 Enzyme Responsible for the Production of (Z)-Norendoxifen in vitro.. Chem Biodivers, 15 (1): (589-97). [PMID:28834279] |
3. Helland T, Henne N, Bifulco E, Naume B, Borgen E, Kristensen VN, Kvaløy JT, Lash TL, Alnæs GIG, van Schaik RH et al.. (2017) Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients.. Breast Cancer Res, 19 (1): (125). [PMID:29183390] |
4. Shagufta, Ahmad I. (2018) Tamoxifen a pioneering drug: An update on the therapeutic potential of tamoxifen derivatives.. Eur J Med Chem, 143 (3): (515-531). [PMID:29207335] |
5. Skaar TC, Desta Z. (2018) CYP2D6 and Endoxifen in Tamoxifen Therapy: A Tribute to David A. Flockhart.. Clin Pharmacol Ther, 103 (5): (755-757). [PMID:29473149] |
6. Sanchez-Spitman A, Dezentjé V, Swen J, Moes DJAR, Böhringer S, Batman E, van Druten E, Smorenburg C, van Bochove A, Zeillemaker A et al.. (2019) Tamoxifen Pharmacogenetics and Metabolism: Results From the Prospective CYPTAM Study.. J Clin Oncol, 37 (8): (636-646). [PMID:30676859] |